VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,010,000 | +27.2% | 27,056 | +13.7% | 0.03% | +23.1% |
| Q1 2015 | $4,725,000 | +68.4% | 23,787 | +21.4% | 0.03% | +62.5% |
| Q4 2014 | $2,805,000 | -47.4% | 19,600 | -51.8% | 0.02% | -51.5% |
| Q3 2014 | $5,332,000 | +76.0% | 40,642 | +69.2% | 0.03% | +83.3% |
| Q2 2014 | $3,030,000 | -54.4% | 24,023 | -52.3% | 0.02% | -55.0% |
| Q1 2014 | $6,638,000 | +55.1% | 50,352 | +38.1% | 0.04% | +42.9% |
| Q4 2013 | $4,281,000 | +120.8% | 36,464 | +96.2% | 0.03% | +115.4% |
| Q3 2013 | $1,939,000 | -44.9% | 18,581 | -54.6% | 0.01% | -45.8% |
| Q2 2013 | $3,521,000 | – | 40,905 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |